Encompass Health Corp Stock Cash And Equivalents
| EHC Stock | USD 113.88 4.38 4.00% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Encompass Health's long-term financial health and intrinsic value.
Encompass | Build AI portfolio with Encompass Stock |
Encompass Health Corp Company Cash And Equivalents Analysis
Encompass Health's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current Encompass Health Cash And Equivalents | 85.4 M |
Most of Encompass Health's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Encompass Health Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
| Competition |
In accordance with the recently published financial statements, Encompass Health Corp has 85.4 M in Cash And Equivalents. This is 89.6% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The cash and equivalents for all United States stocks is 96.84% higher than that of the company.
Encompass Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Encompass Health's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Encompass Health could also be used in its relative valuation, which is a method of valuing Encompass Health by comparing valuation metrics of similar companies.Encompass Health is currently under evaluation in cash and equivalents category among its peers.
Encompass Fundamentals
| Return On Equity | 0.25 | ||||
| Return On Asset | 0.0897 | ||||
| Profit Margin | 0.09 % | ||||
| Operating Margin | 0.18 % | ||||
| Current Valuation | 13.55 B | ||||
| Shares Outstanding | 100.8 M | ||||
| Shares Owned By Insiders | 1.40 % | ||||
| Shares Owned By Institutions | 97.08 % | ||||
| Number Of Shares Shorted | 988.91 K | ||||
| Price To Earning | 18.73 X | ||||
| Price To Book | 5.07 X | ||||
| Price To Sales | 2.00 X | ||||
| Revenue | 5.37 B | ||||
| Gross Profit | 2.32 B | ||||
| EBITDA | 1.19 B | ||||
| Net Income | 599.4 M | ||||
| Cash And Equivalents | 85.4 M | ||||
| Cash Per Share | 0.60 X | ||||
| Total Debt | 2.71 B | ||||
| Debt To Equity | 1.69 % | ||||
| Current Ratio | 1.21 X | ||||
| Book Value Per Share | 21.40 X | ||||
| Cash Flow From Operations | 1 B | ||||
| Short Ratio | 1.08 X | ||||
| Earnings Per Share | 4.86 X | ||||
| Price To Earnings To Growth | 1.37 X | ||||
| Target Price | 131.58 | ||||
| Number Of Employees | 28.57 K | ||||
| Beta | 0.74 | ||||
| Market Capitalization | 11.04 B | ||||
| Total Asset | 6.53 B | ||||
| Retained Earnings | 796.7 M | ||||
| Working Capital | 45.9 M | ||||
| Current Asset | 659.58 M | ||||
| Current Liabilities | 474.74 M | ||||
| Annual Yield | 0.01 % | ||||
| Five Year Return | 1.65 % | ||||
| Net Asset | 6.53 B | ||||
| Last Dividend Paid | 0.66 |
About Encompass Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Encompass Health Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Encompass Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Encompass Health Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Encompass Health Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Encompass Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Encompass Health Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Encompass Health Corp Stock:Check out Encompass Health Piotroski F Score and Encompass Health Altman Z Score analysis. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Healthcare space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Encompass Health. If investors know Encompass will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Encompass Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Encompass Health Corp is measured differently than its book value, which is the value of Encompass that is recorded on the company's balance sheet. Investors also form their own opinion of Encompass Health's value that differs from its market value or its book value, called intrinsic value, which is Encompass Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Encompass Health's market value can be influenced by many factors that don't directly affect Encompass Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Encompass Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Encompass Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Encompass Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.